138 related articles for article (PubMed ID: 29857328)
1. Increased expression of CRF and CRF-receptors in dorsal striatum, hippocampus, and prefrontal cortex after the development of nicotine sensitization in rats.
Carboni L; Romoli B; Bate ST; Romualdi P; Zoli M
Drug Alcohol Depend; 2018 Aug; 189():12-20. PubMed ID: 29857328
[TBL] [Abstract][Full Text] [Related]
2. Changes in striatal dopamine release and locomotor activity following acute withdrawal from chronic nicotine are mediated by CRF1, but not CRF2, receptors.
Buzás A; Bokor P; Balangó B; Pintér D; Palotai M; Simon B; Csabafi K; Telegdy G; Szabó G; Bagosi Z
Brain Res; 2019 Mar; 1706():41-47. PubMed ID: 30722977
[TBL] [Abstract][Full Text] [Related]
3. Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal.
Qi X; Shan Z; Ji Y; Guerra V; Alexander JC; Ormerod BK; Bruijnzeel AW
Transl Psychiatry; 2014 Apr; 4(4):e385. PubMed ID: 24755994
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
Bruijnzeel AW; Prado M; Isaac S
Biol Psychiatry; 2009 Jul; 66(2):110-7. PubMed ID: 19217073
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.
Qi X; Guzhva L; Yang Z; Febo M; Shan Z; Wang KKW; Bruijnzeel AW
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1378-1389. PubMed ID: 27461514
[TBL] [Abstract][Full Text] [Related]
6. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of corticotropin-releasing factor CRF
Ferrer-Pérez C; Reguilón MD; Manzanedo C; Aguilar MA; Miñarro J; Rodríguez-Arias M
Eur J Pharmacol; 2018 Mar; 823():87-95. PubMed ID: 29391155
[TBL] [Abstract][Full Text] [Related]
8. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
9. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
[TBL] [Abstract][Full Text] [Related]
10. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain.
Korosi A; Veening JG; Kozicz T; Henckens M; Dederen J; Groenink L; van der Gugten J; Olivier B; Roubos EW
Brain Res; 2006 Feb; 1072(1):46-54. PubMed ID: 16423327
[TBL] [Abstract][Full Text] [Related]
11. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
Sergio Tde O; Spiacci A; Zangrossi H
Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
[TBL] [Abstract][Full Text] [Related]
12. Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach.
Jastrzębska J; Nowak E; Smaga I; Bystrowska B; Frankowska M; Bader M; Filip M; Fuxe K
Neuropharmacology; 2014 Jun; 81():318-26. PubMed ID: 24632528
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
Nozu T; Okumura T
J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
[TBL] [Abstract][Full Text] [Related]
14. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
Mansi JA; Rivest S; Drolet G
Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
Primus RJ; Yevich E; Baltazar C; Gallager DW
Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.
Aydin C; Oztan O; Isgor C
Behav Brain Res; 2011 Sep; 222(2):332-41. PubMed ID: 21497168
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
Bruijnzeel AW; Zislis G; Wilson C; Gold MS
Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
[TBL] [Abstract][Full Text] [Related]
18. Binge Drinking Decreases Corticotropin-Releasing Factor-Binding Protein Expression in the Medial Prefrontal Cortex of Mice.
Ketchesin KD; Stinnett GS; Seasholtz AF
Alcohol Clin Exp Res; 2016 Aug; 40(8):1641-50. PubMed ID: 27374820
[TBL] [Abstract][Full Text] [Related]
19. Repeated nicotine exposure modulates prodynorphin and pronociceptin levels in the reward pathway.
Carboni L; Romoli B; Romualdi P; Zoli M
Drug Alcohol Depend; 2016 Sep; 166():150-8. PubMed ID: 27430399
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ
Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
